Natco Pharma is currently trading at Rs. 1047.85, up by 27.00 points or 2.64% from its previous closing of Rs. 1020.85 on the BSE.
The scrip opened at Rs. 1034.85 and has touched a high and low of Rs. 1061.95 and Rs. 1034.85 respectively. So far 2,620 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1080.00 on 09-Jun-2017 and a 52 week low of Rs. 555.50 on 26-Dec-2016.
Last one week high and low of the scrip stood at Rs. 1061.95 and Rs. 931.70 respectively. The current market cap of the company is Rs. 18,233.00 crore.
The promoters holding in the company stood at 51.19%, while Institutions and Non-Institutions held 26.94% and 21.87% respectively.
Natco Pharma has raised Rs 915 crore through issue of securities to Qualified Institutional Investors. The company’s committee of directors decided to allocate 1 crore shares at issue price of Rs 915 per share. The shares were allotted to eligible qualified institutional buyers pursuant to the QIP amounting to an issue size of Rs 915 crore.
Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: